- Previous Close
9.18 - Open
9.16 - Bid 8.43 x --
- Ask 8.44 x --
- Day's Range
8.41 - 9.22 - 52 Week Range
5.76 - 11.48 - Volume
39,177,756 - Avg. Volume
17,636,188 - Market Cap (intraday)
6.999B - Beta (5Y Monthly) -0.05
- PE Ratio (TTM)
26.34 - EPS (TTM)
0.32 - Earnings Date --
- Forward Dividend & Yield 0.13 (1.53%)
- Ex-Dividend Date Jul 12, 2024
- 1y Target Est
--
Zhejiang Ausun Pharmaceutical Co., Ltd. engages in the research and development, process development, manufacture, and sale of APIs and pharmaceutical intermediates. It offers fluorine products, prostaglandins, antimicrobials, and oncology products. The company also provides products for liver disease, respiratory system, and cardiac and cerebral vessels, as well as CNS indications. In addition, it offers development and manufacturing services to the pharmaceutical, cosmetics, and nutritional industries. The company was founded in 2010 and is based in Linhai, China.
www.ausunpharm.comRecent News: 603229.SS
View MorePerformance Overview: 603229.SS
Trailing total returns as of 1/10/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 603229.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 603229.SS
View MoreValuation Measures
Market Cap
7.00B
Enterprise Value
6.28B
Trailing P/E
26.58
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
8.22
Price/Book (mrq)
3.05
Enterprise Value/Revenue
7.52
Enterprise Value/EBITDA
20.69
Financial Highlights
Profitability and Income Statement
Profit Margin
30.84%
Return on Assets (ttm)
5.57%
Return on Equity (ttm)
11.69%
Revenue (ttm)
835.23M
Net Income Avi to Common (ttm)
257.55M
Diluted EPS (ttm)
0.32
Balance Sheet and Cash Flow
Total Cash (mrq)
1.03B
Total Debt/Equity (mrq)
13.21%
Levered Free Cash Flow (ttm)
-107.65M